nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—PGR—polycystic ovary syndrome	0.344	0.446	CbGaD
Betamethasone—CYP19A1—polycystic ovary syndrome	0.236	0.306	CbGaD
Betamethasone—NR3C1—polycystic ovary syndrome	0.191	0.248	CbGaD
Betamethasone—CYP19A1—follicular fluid—polycystic ovary syndrome	0.0204	0.179	CbGeAlD
Betamethasone—PGR—corpus luteum—polycystic ovary syndrome	0.0131	0.114	CbGeAlD
Betamethasone—CYP19A1—corpus luteum—polycystic ovary syndrome	0.0118	0.103	CbGeAlD
Betamethasone—PGR—ovarian follicle—polycystic ovary syndrome	0.0102	0.0894	CbGeAlD
Betamethasone—CYP19A1—ovarian follicle—polycystic ovary syndrome	0.00921	0.0805	CbGeAlD
Betamethasone—PTGS2—ovarian follicle—polycystic ovary syndrome	0.00511	0.0447	CbGeAlD
Betamethasone—NR3C1—urine—polycystic ovary syndrome	0.00247	0.0216	CbGeAlD
Betamethasone—PLA2G1B—pituitary gland—polycystic ovary syndrome	0.00199	0.0174	CbGeAlD
Betamethasone—CYP3A4—urine—polycystic ovary syndrome	0.00187	0.0163	CbGeAlD
Betamethasone—PLA2G1B—adrenal gland—polycystic ovary syndrome	0.00178	0.0155	CbGeAlD
Betamethasone—PLA2G1B—female gonad—polycystic ovary syndrome	0.00166	0.0145	CbGeAlD
Betamethasone—PLA2G1B—endocrine gland—polycystic ovary syndrome	0.00154	0.0135	CbGeAlD
Betamethasone—NR3C2—adrenal cortex—polycystic ovary syndrome	0.00122	0.0107	CbGeAlD
Betamethasone—NR3C2—endometrium—polycystic ovary syndrome	0.00109	0.00952	CbGeAlD
Betamethasone—PGR—endometrium—polycystic ovary syndrome	0.00101	0.00885	CbGeAlD
Betamethasone—NR3C2—uterus—polycystic ovary syndrome	0.001	0.00877	CbGeAlD
Betamethasone—NR3C2—pituitary gland—polycystic ovary syndrome	0.000985	0.00861	CbGeAlD
Betamethasone—NR3C2—adipose tissue—polycystic ovary syndrome	0.000981	0.00858	CbGeAlD
Betamethasone—PGR—uterus—polycystic ovary syndrome	0.000933	0.00815	CbGeAlD
Betamethasone—PGR—pituitary gland—polycystic ovary syndrome	0.000916	0.00801	CbGeAlD
Betamethasone—PGR—adipose tissue—polycystic ovary syndrome	0.000912	0.00797	CbGeAlD
Betamethasone—CYP19A1—endometrium—polycystic ovary syndrome	0.000911	0.00796	CbGeAlD
Betamethasone—NR3C2—adrenal gland—polycystic ovary syndrome	0.00088	0.0077	CbGeAlD
Betamethasone—CYP19A1—uterus—polycystic ovary syndrome	0.000839	0.00734	CbGeAlD
Betamethasone—CYP19A1—adipose tissue—polycystic ovary syndrome	0.000821	0.00718	CbGeAlD
Betamethasone—NR3C2—female gonad—polycystic ovary syndrome	0.000821	0.00718	CbGeAlD
Betamethasone—PGR—adrenal gland—polycystic ovary syndrome	0.000818	0.00715	CbGeAlD
Betamethasone—NR3C2—vagina—polycystic ovary syndrome	0.000816	0.00713	CbGeAlD
Betamethasone—NR3C1—embryo—polycystic ovary syndrome	0.000798	0.00698	CbGeAlD
Betamethasone—NR3C2—endocrine gland—polycystic ovary syndrome	0.000763	0.00667	CbGeAlD
Betamethasone—PGR—female gonad—polycystic ovary syndrome	0.000763	0.00667	CbGeAlD
Betamethasone—PGR—vagina—polycystic ovary syndrome	0.000758	0.00663	CbGeAlD
Betamethasone—CYP19A1—adrenal gland—polycystic ovary syndrome	0.000736	0.00644	CbGeAlD
Betamethasone—PGR—endocrine gland—polycystic ovary syndrome	0.00071	0.0062	CbGeAlD
Betamethasone—PTGS2—embryo—polycystic ovary syndrome	0.000691	0.00604	CbGeAlD
Betamethasone—CYP19A1—female gonad—polycystic ovary syndrome	0.000687	0.006	CbGeAlD
Betamethasone—NR3C1—adrenal cortex—polycystic ovary syndrome	0.000654	0.00572	CbGeAlD
Betamethasone—CYP19A1—endocrine gland—polycystic ovary syndrome	0.000639	0.00558	CbGeAlD
Betamethasone—NR3C1—endometrium—polycystic ovary syndrome	0.000584	0.00511	CbGeAlD
Betamethasone—PTGS2—adrenal cortex—polycystic ovary syndrome	0.000566	0.00495	CbGeAlD
Betamethasone—NR3C1—uterus—polycystic ovary syndrome	0.000538	0.0047	CbGeAlD
Betamethasone—NR3C1—pituitary gland—polycystic ovary syndrome	0.000529	0.00462	CbGeAlD
Betamethasone—NR3C1—adipose tissue—polycystic ovary syndrome	0.000526	0.0046	CbGeAlD
Betamethasone—PTGS2—endometrium—polycystic ovary syndrome	0.000506	0.00442	CbGeAlD
Betamethasone—NR3C1—adrenal gland—polycystic ovary syndrome	0.000472	0.00413	CbGeAlD
Betamethasone—PTGS2—uterus—polycystic ovary syndrome	0.000466	0.00407	CbGeAlD
Betamethasone—PTGS2—pituitary gland—polycystic ovary syndrome	0.000457	0.004	CbGeAlD
Betamethasone—PTGS2—adipose tissue—polycystic ovary syndrome	0.000456	0.00398	CbGeAlD
Betamethasone—NR3C1—female gonad—polycystic ovary syndrome	0.00044	0.00385	CbGeAlD
Betamethasone—NR3C1—vagina—polycystic ovary syndrome	0.000438	0.00383	CbGeAlD
Betamethasone—ABCB1—embryo—polycystic ovary syndrome	0.000427	0.00374	CbGeAlD
Betamethasone—NR3C1—endocrine gland—polycystic ovary syndrome	0.000409	0.00358	CbGeAlD
Betamethasone—PTGS2—adrenal gland—polycystic ovary syndrome	0.000409	0.00357	CbGeAlD
Betamethasone—PTGS2—female gonad—polycystic ovary syndrome	0.000381	0.00333	CbGeAlD
Betamethasone—PTGS2—vagina—polycystic ovary syndrome	0.000379	0.00331	CbGeAlD
Betamethasone—PTGS2—endocrine gland—polycystic ovary syndrome	0.000354	0.0031	CbGeAlD
Betamethasone—ABCB1—adrenal cortex—polycystic ovary syndrome	0.00035	0.00306	CbGeAlD
Betamethasone—ABCB1—endometrium—polycystic ovary syndrome	0.000313	0.00273	CbGeAlD
Betamethasone—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00031	0.00271	CbGeAlD
Betamethasone—Testolactone—CYP19A1—polycystic ovary syndrome	0.000306	0.0423	CrCbGaD
Betamethasone—ABCB1—uterus—polycystic ovary syndrome	0.000288	0.00252	CbGeAlD
Betamethasone—ABCB1—pituitary gland—polycystic ovary syndrome	0.000283	0.00247	CbGeAlD
Betamethasone—ABCB1—adipose tissue—polycystic ovary syndrome	0.000282	0.00246	CbGeAlD
Betamethasone—Difluprednate—NR3C1—polycystic ovary syndrome	0.000256	0.0354	CrCbGaD
Betamethasone—ABCB1—adrenal gland—polycystic ovary syndrome	0.000253	0.00221	CbGeAlD
Betamethasone—Clocortolone—NR3C1—polycystic ovary syndrome	0.000248	0.0343	CrCbGaD
Betamethasone—Prednicarbate—NR3C1—polycystic ovary syndrome	0.000248	0.0343	CrCbGaD
Betamethasone—Fungal infection—Metformin—polycystic ovary syndrome	0.000236	0.0672	CcSEcCtD
Betamethasone—ABCB1—female gonad—polycystic ovary syndrome	0.000236	0.00206	CbGeAlD
Betamethasone—Desonide—NR3C1—polycystic ovary syndrome	0.000235	0.0325	CrCbGaD
Betamethasone—Diflorasone—NR3C1—polycystic ovary syndrome	0.000235	0.0325	CrCbGaD
Betamethasone—ABCB1—vagina—polycystic ovary syndrome	0.000234	0.00205	CbGeAlD
Betamethasone—Desoximetasone—NR3C1—polycystic ovary syndrome	0.000229	0.0317	CrCbGaD
Betamethasone—Loteprednol—NR3C1—polycystic ovary syndrome	0.000226	0.0313	CrCbGaD
Betamethasone—Fludrocortisone—AR—polycystic ovary syndrome	0.000223	0.0308	CrCbGaD
Betamethasone—ABCB1—endocrine gland—polycystic ovary syndrome	0.000219	0.00192	CbGeAlD
Betamethasone—Fluoxymesterone—SHBG—polycystic ovary syndrome	0.00021	0.029	CrCbGaD
Betamethasone—Contusion—Metformin—polycystic ovary syndrome	0.000209	0.0595	CcSEcCtD
Betamethasone—Flurandrenolide—NR3C1—polycystic ovary syndrome	0.000201	0.0277	CrCbGaD
Betamethasone—Flumethasone Pivalate—NR3C1—polycystic ovary syndrome	0.000197	0.0272	CrCbGaD
Betamethasone—Halobetasol Propionate—NR3C1—polycystic ovary syndrome	0.000194	0.0268	CrCbGaD
Betamethasone—Fluticasone Propionate—PGR—polycystic ovary syndrome	0.000191	0.0264	CrCbGaD
Betamethasone—Fluoxymesterone—AR—polycystic ovary syndrome	0.000184	0.0255	CrCbGaD
Betamethasone—Budesonide—NR3C1—polycystic ovary syndrome	0.00018	0.0249	CrCbGaD
Betamethasone—Amcinonide—NR3C1—polycystic ovary syndrome	0.00018	0.0249	CrCbGaD
Betamethasone—Fluticasone furoate—NR3C1—polycystic ovary syndrome	0.000177	0.0244	CrCbGaD
Betamethasone—Mometasone—NR3C1—polycystic ovary syndrome	0.000172	0.0237	CrCbGaD
Betamethasone—Neuropathy—Metformin—polycystic ovary syndrome	0.000171	0.0487	CcSEcCtD
Betamethasone—Rimexolone—NR3C1—polycystic ovary syndrome	0.00017	0.0234	CrCbGaD
Betamethasone—Fluocinonide—NR3C1—polycystic ovary syndrome	0.00016	0.0221	CrCbGaD
Betamethasone—Beclomethasone—NR3C1—polycystic ovary syndrome	0.00016	0.0221	CrCbGaD
Betamethasone—Fluocinolone Acetonide—NR3C1—polycystic ovary syndrome	0.000155	0.0215	CrCbGaD
Betamethasone—Alclometasone—NR3C1—polycystic ovary syndrome	0.000155	0.0215	CrCbGaD
Betamethasone—Flunisolide—NR3C1—polycystic ovary syndrome	0.000151	0.0209	CrCbGaD
Betamethasone—Clobetasol propionate—NR3C1—polycystic ovary syndrome	0.000151	0.0209	CrCbGaD
Betamethasone—Fludrocortisone—NR3C1—polycystic ovary syndrome	0.000151	0.0209	CrCbGaD
Betamethasone—Paramethasone—NR3C1—polycystic ovary syndrome	0.000149	0.0206	CrCbGaD
Betamethasone—Fluorometholone—NR3C1—polycystic ovary syndrome	0.000146	0.0202	CrCbGaD
Betamethasone—Injury—Metformin—polycystic ovary syndrome	0.000144	0.041	CcSEcCtD
Betamethasone—Methylprednisolone—NR3C1—polycystic ovary syndrome	0.000141	0.0195	CrCbGaD
Betamethasone—Dexamethasone—CYP17A1—polycystic ovary syndrome	0.000137	0.019	CrCbGaD
Betamethasone—Clobetasol propionate—CYP1A1—polycystic ovary syndrome	0.000137	0.019	CrCbGaD
Betamethasone—Dexamethasone—CYP11A1—polycystic ovary syndrome	0.000135	0.0187	CrCbGaD
Betamethasone—Lethargy—Metformin—polycystic ovary syndrome	0.000135	0.0384	CcSEcCtD
Betamethasone—Migraine—Metformin—polycystic ovary syndrome	0.00013	0.0371	CcSEcCtD
Betamethasone—Hydrocortisone—SHBG—polycystic ovary syndrome	0.000128	0.0177	CrCbGaD
Betamethasone—Fluoxymesterone—NR3C1—polycystic ovary syndrome	0.000125	0.0173	CrCbGaD
Betamethasone—Triamcinolone—NR3C1—polycystic ovary syndrome	0.000119	0.0164	CrCbGaD
Betamethasone—Sweating increased—Metformin—polycystic ovary syndrome	0.000111	0.0317	CcSEcCtD
Betamethasone—Prednisone—NR3C1—polycystic ovary syndrome	0.000108	0.0149	CrCbGaD
Betamethasone—Fluticasone Propionate—NR3C1—polycystic ovary syndrome	0.000106	0.0147	CrCbGaD
Betamethasone—Dexamethasone—PGR—polycystic ovary syndrome	0.000102	0.0141	CrCbGaD
Betamethasone—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.0001	0.0285	CcSEcCtD
Betamethasone—Prednisolone—NR3C1—polycystic ovary syndrome	9.94e-05	0.0137	CrCbGaD
Betamethasone—Bradycardia—Metformin—polycystic ovary syndrome	9.32e-05	0.0265	CcSEcCtD
Betamethasone—Eye disorder—Metformin—polycystic ovary syndrome	8.56e-05	0.0244	CcSEcCtD
Betamethasone—Angiopathy—Metformin—polycystic ovary syndrome	8.31e-05	0.0236	CcSEcCtD
Betamethasone—Erythema—Metformin—polycystic ovary syndrome	7.97e-05	0.0227	CcSEcCtD
Betamethasone—Hydrocortisone—NR3C1—polycystic ovary syndrome	7.6e-05	0.0105	CrCbGaD
Betamethasone—Ill-defined disorder—Metformin—polycystic ovary syndrome	7.4e-05	0.0211	CcSEcCtD
Betamethasone—Malaise—Metformin—polycystic ovary syndrome	7.19e-05	0.0205	CcSEcCtD
Betamethasone—Syncope—Metformin—polycystic ovary syndrome	7.15e-05	0.0203	CcSEcCtD
Betamethasone—Loss of consciousness—Metformin—polycystic ovary syndrome	7.01e-05	0.0199	CcSEcCtD
Betamethasone—Dexamethasone—CYP19A1—polycystic ovary syndrome	6.99e-05	0.00966	CrCbGaD
Betamethasone—Hypertension—Metformin—polycystic ovary syndrome	6.88e-05	0.0196	CcSEcCtD
Betamethasone—Myalgia—Metformin—polycystic ovary syndrome	6.79e-05	0.0193	CcSEcCtD
Betamethasone—Discomfort—Metformin—polycystic ovary syndrome	6.7e-05	0.0191	CcSEcCtD
Betamethasone—Oedema—Metformin—polycystic ovary syndrome	6.5e-05	0.0185	CcSEcCtD
Betamethasone—Infection—Metformin—polycystic ovary syndrome	6.46e-05	0.0184	CcSEcCtD
Betamethasone—Shock—Metformin—polycystic ovary syndrome	6.4e-05	0.0182	CcSEcCtD
Betamethasone—Nervous system disorder—Metformin—polycystic ovary syndrome	6.38e-05	0.0182	CcSEcCtD
Betamethasone—Thrombocytopenia—Metformin—polycystic ovary syndrome	6.37e-05	0.0181	CcSEcCtD
Betamethasone—Hyperhidrosis—Metformin—polycystic ovary syndrome	6.29e-05	0.0179	CcSEcCtD
Betamethasone—Anorexia—Metformin—polycystic ovary syndrome	6.2e-05	0.0177	CcSEcCtD
Betamethasone—Hypotension—Metformin—polycystic ovary syndrome	6.08e-05	0.0173	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	5.93e-05	0.0169	CcSEcCtD
Betamethasone—Paraesthesia—Metformin—polycystic ovary syndrome	5.84e-05	0.0166	CcSEcCtD
Betamethasone—Dyspepsia—Metformin—polycystic ovary syndrome	5.73e-05	0.0163	CcSEcCtD
Betamethasone—Dexamethasone—NR3C1—polycystic ovary syndrome	5.67e-05	0.00783	CrCbGaD
Betamethasone—Decreased appetite—Metformin—polycystic ovary syndrome	5.65e-05	0.0161	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	5.62e-05	0.016	CcSEcCtD
Betamethasone—Fatigue—Metformin—polycystic ovary syndrome	5.61e-05	0.016	CcSEcCtD
Betamethasone—Feeling abnormal—Metformin—polycystic ovary syndrome	5.36e-05	0.0153	CcSEcCtD
Betamethasone—Gastrointestinal pain—Metformin—polycystic ovary syndrome	5.32e-05	0.0151	CcSEcCtD
Betamethasone—Urticaria—Metformin—polycystic ovary syndrome	5.17e-05	0.0147	CcSEcCtD
Betamethasone—Dexamethasone—CYP1A1—polycystic ovary syndrome	5.15e-05	0.00711	CrCbGaD
Betamethasone—Abdominal pain—Metformin—polycystic ovary syndrome	5.14e-05	0.0146	CcSEcCtD
Betamethasone—Asthenia—Metformin—polycystic ovary syndrome	4.67e-05	0.0133	CcSEcCtD
Betamethasone—Pruritus—Metformin—polycystic ovary syndrome	4.6e-05	0.0131	CcSEcCtD
Betamethasone—Diarrhoea—Metformin—polycystic ovary syndrome	4.45e-05	0.0127	CcSEcCtD
Betamethasone—Dizziness—Metformin—polycystic ovary syndrome	4.3e-05	0.0122	CcSEcCtD
Betamethasone—PTGS2—Metabolism—LPCAT2—polycystic ovary syndrome	4.28e-05	0.000412	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SUOX—polycystic ovary syndrome	4.28e-05	0.000412	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PNPLA2—polycystic ovary syndrome	4.24e-05	0.000409	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	4.23e-05	0.000407	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	4.2e-05	0.000404	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—TNRC6B—polycystic ovary syndrome	4.19e-05	0.000403	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	4.19e-05	0.000403	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—polycystic ovary syndrome	4.14e-05	0.000399	CbGpPWpGaD
Betamethasone—Vomiting—Metformin—polycystic ovary syndrome	4.14e-05	0.0118	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—GNAS—polycystic ovary syndrome	4.13e-05	0.000398	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—polycystic ovary syndrome	4.12e-05	0.000396	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—RACGAP1—polycystic ovary syndrome	4.1e-05	0.000395	CbGpPWpGaD
Betamethasone—Rash—Metformin—polycystic ovary syndrome	4.1e-05	0.0117	CcSEcCtD
Betamethasone—Dermatitis—Metformin—polycystic ovary syndrome	4.1e-05	0.0117	CcSEcCtD
Betamethasone—NR3C1—Gene Expression—RPL37A—polycystic ovary syndrome	4.09e-05	0.000394	CbGpPWpGaD
Betamethasone—Headache—Metformin—polycystic ovary syndrome	4.08e-05	0.0116	CcSEcCtD
Betamethasone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	4.02e-05	0.000387	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—SRD5A1—polycystic ovary syndrome	4.02e-05	0.000387	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ADRA1A—polycystic ovary syndrome	3.99e-05	0.000384	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ISYNA1—polycystic ovary syndrome	3.98e-05	0.000383	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—NCOR1—polycystic ovary syndrome	3.93e-05	0.000379	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	3.92e-05	0.000377	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	3.89e-05	0.000374	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FST—polycystic ovary syndrome	3.89e-05	0.000374	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—AR—polycystic ovary syndrome	3.87e-05	0.000373	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	3.87e-05	0.000372	CbGpPWpGaD
Betamethasone—Nausea—Metformin—polycystic ovary syndrome	3.86e-05	0.011	CcSEcCtD
Betamethasone—PGR—Signaling Pathways—ADRB3—polycystic ovary syndrome	3.84e-05	0.00037	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—STAR—polycystic ovary syndrome	3.84e-05	0.00037	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	3.8e-05	0.000366	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—LHB—polycystic ovary syndrome	3.8e-05	0.000365	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	3.78e-05	0.000364	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CYP1A1—polycystic ovary syndrome	3.73e-05	0.000359	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—GNRH1—polycystic ovary syndrome	3.71e-05	0.000357	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	3.65e-05	0.000351	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	3.64e-05	0.000351	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	3.63e-05	0.00035	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	3.59e-05	0.000346	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKR1C1—polycystic ovary syndrome	3.59e-05	0.000346	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	3.57e-05	0.000343	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SCT—polycystic ovary syndrome	3.56e-05	0.000342	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	3.56e-05	0.000342	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	3.51e-05	0.000338	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—MTHFR—polycystic ovary syndrome	3.48e-05	0.000335	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	3.45e-05	0.000332	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—HMMR—polycystic ovary syndrome	3.42e-05	0.000329	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MTNR1B—polycystic ovary syndrome	3.39e-05	0.000327	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—TEAD2—polycystic ovary syndrome	3.38e-05	0.000326	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AKR1C2—polycystic ovary syndrome	3.38e-05	0.000326	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—NCOR1—polycystic ovary syndrome	3.38e-05	0.000326	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FGF18—polycystic ovary syndrome	3.34e-05	0.000321	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	3.32e-05	0.000319	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—PPARG—polycystic ovary syndrome	3.32e-05	0.000319	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—RBP4—polycystic ovary syndrome	3.31e-05	0.000318	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	3.29e-05	0.000317	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—HSD3B1—polycystic ovary syndrome	3.26e-05	0.000314	CbGpPWpGaD
Betamethasone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	3.26e-05	0.000314	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	3.25e-05	0.000313	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	3.23e-05	0.000311	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—AR—polycystic ovary syndrome	3.22e-05	0.00031	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	3.2e-05	0.000308	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—YAP1—polycystic ovary syndrome	3.09e-05	0.000297	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	3.06e-05	0.000295	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	3.06e-05	0.000294	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—GAB1—polycystic ovary syndrome	3.05e-05	0.000293	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	3.04e-05	0.000292	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	3.04e-05	0.000292	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—SERPINE1—polycystic ovary syndrome	2.99e-05	0.000288	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—LHB—polycystic ovary syndrome	2.98e-05	0.000287	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	2.95e-05	0.000284	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—INSR—polycystic ovary syndrome	2.91e-05	0.00028	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—HSD3B2—polycystic ovary syndrome	2.91e-05	0.00028	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	2.88e-05	0.000278	CbGpPWpGaD
Betamethasone—PTGS2—Disease—RPL37A—polycystic ovary syndrome	2.88e-05	0.000277	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—IL6—polycystic ovary syndrome	2.85e-05	0.000274	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	2.84e-05	0.000274	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PNPLA2—polycystic ovary syndrome	2.84e-05	0.000273	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	2.82e-05	0.000272	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PPARG—polycystic ovary syndrome	2.82e-05	0.000271	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—NCOR1—polycystic ovary syndrome	2.82e-05	0.000271	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AKR1C1—polycystic ovary syndrome	2.82e-05	0.000271	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—POMC—polycystic ovary syndrome	2.78e-05	0.000268	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKR1C3—polycystic ovary syndrome	2.77e-05	0.000266	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—INS—polycystic ovary syndrome	2.77e-05	0.000266	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—YAP1—polycystic ovary syndrome	2.74e-05	0.000264	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HMMR—polycystic ovary syndrome	2.73e-05	0.000263	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TNRC6B—polycystic ovary syndrome	2.72e-05	0.000262	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SRD5A1—polycystic ovary syndrome	2.69e-05	0.000259	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—NR3C1—polycystic ovary syndrome	2.61e-05	0.000251	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—SULT2A1—polycystic ovary syndrome	2.59e-05	0.00025	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—STAR—polycystic ovary syndrome	2.56e-05	0.000247	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.54e-05	0.000244	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—RRM2—polycystic ovary syndrome	2.51e-05	0.000242	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PLAT—polycystic ovary syndrome	2.51e-05	0.000241	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—GHRL—polycystic ovary syndrome	2.51e-05	0.000241	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	2.49e-05	0.00024	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	2.46e-05	0.000237	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—PPARG—polycystic ovary syndrome	2.43e-05	0.000233	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—TNRC6B—polycystic ovary syndrome	2.42e-05	0.000233	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—YAP1—polycystic ovary syndrome	2.42e-05	0.000233	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	2.4e-05	0.000231	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	2.4e-05	0.000231	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—PGR—polycystic ovary syndrome	2.4e-05	0.000231	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ATF1—polycystic ovary syndrome	2.39e-05	0.00023	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.33e-05	0.000224	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—IL6—polycystic ovary syndrome	2.33e-05	0.000224	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—NAMPT—polycystic ovary syndrome	2.33e-05	0.000224	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	2.32e-05	0.000224	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.31e-05	0.000223	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CYP11A1—polycystic ovary syndrome	2.3e-05	0.000221	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	2.29e-05	0.000221	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	2.29e-05	0.000221	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—HMMR—polycystic ovary syndrome	2.29e-05	0.00022	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.28e-05	0.00022	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKR1C1—polycystic ovary syndrome	2.25e-05	0.000216	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NGFR—polycystic ovary syndrome	2.21e-05	0.000212	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PRL—polycystic ovary syndrome	2.19e-05	0.000211	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—SERPINE1—polycystic ovary syndrome	2.18e-05	0.00021	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—HSD3B1—polycystic ovary syndrome	2.18e-05	0.00021	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	2.17e-05	0.000209	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AKR1C3—polycystic ovary syndrome	2.17e-05	0.000209	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.16e-05	0.000208	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.14e-05	0.000206	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CYP17A1—polycystic ovary syndrome	2.14e-05	0.000206	CbGpPWpGaD
Betamethasone—PTGS2—Disease—FGF18—polycystic ovary syndrome	2.09e-05	0.000201	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.07e-05	0.0002	CbGpPWpGaD
Betamethasone—PTGS2—Disease—RBP4—polycystic ovary syndrome	2.07e-05	0.000199	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	2.04e-05	0.000197	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.04e-05	0.000197	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—PPARG—polycystic ovary syndrome	2.02e-05	0.000194	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	2.01e-05	0.000194	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—LHB—polycystic ovary syndrome	1.99e-05	0.000191	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	1.99e-05	0.000191	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	1.94e-05	0.000187	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—GNAS—polycystic ovary syndrome	1.92e-05	0.000185	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	1.91e-05	0.000183	CbGpPWpGaD
Betamethasone—PTGS2—Disease—GAB1—polycystic ovary syndrome	1.9e-05	0.000183	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	1.88e-05	0.000181	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	1.87e-05	0.00018	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	1.87e-05	0.00018	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—AR—polycystic ovary syndrome	1.86e-05	0.000179	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NAMPT—polycystic ovary syndrome	1.86e-05	0.000179	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—TH—polycystic ovary syndrome	1.85e-05	0.000178	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NCOR1—polycystic ovary syndrome	1.83e-05	0.000176	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—SERPINE1—polycystic ovary syndrome	1.82e-05	0.000175	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—STAR—polycystic ovary syndrome	1.82e-05	0.000175	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.82e-05	0.000175	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NRG1—polycystic ovary syndrome	1.8e-05	0.000173	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—SLC2A4—polycystic ovary syndrome	1.8e-05	0.000173	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	1.74e-05	0.000167	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	1.73e-05	0.000167	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	1.73e-05	0.000167	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	1.73e-05	0.000167	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	1.7e-05	0.000164	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	1.68e-05	0.000162	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—NCOR1—polycystic ovary syndrome	1.63e-05	0.000157	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	1.63e-05	0.000156	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	1.62e-05	0.000156	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	1.62e-05	0.000156	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	1.55e-05	0.00015	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	1.55e-05	0.000149	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.54e-05	0.000149	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IRS2—polycystic ovary syndrome	1.54e-05	0.000148	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	1.53e-05	0.000148	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.53e-05	0.000147	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.52e-05	0.000147	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GNAS—polycystic ovary syndrome	1.51e-05	0.000145	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—LEP—polycystic ovary syndrome	1.51e-05	0.000145	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	1.48e-05	0.000142	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	1.48e-05	0.000142	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	1.46e-05	0.00014	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	1.45e-05	0.00014	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—NCOR1—polycystic ovary syndrome	1.44e-05	0.000138	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	1.43e-05	0.000138	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	1.43e-05	0.000137	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—LHB—polycystic ovary syndrome	1.41e-05	0.000136	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	1.38e-05	0.000133	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PRL—polycystic ovary syndrome	1.37e-05	0.000132	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CYP1A1—polycystic ovary syndrome	1.36e-05	0.000131	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IRS1—polycystic ovary syndrome	1.35e-05	0.000129	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	1.33e-05	0.000128	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—POMC—polycystic ovary syndrome	1.3e-05	0.000125	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—INS—polycystic ovary syndrome	1.29e-05	0.000124	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—MTHFR—polycystic ovary syndrome	1.27e-05	0.000122	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IGF1—polycystic ovary syndrome	1.25e-05	0.00012	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKT2—polycystic ovary syndrome	1.25e-05	0.00012	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1.24e-05	0.000119	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—TH—polycystic ovary syndrome	1.23e-05	0.000119	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	1.23e-05	0.000118	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	1.2e-05	0.000116	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	1.19e-05	0.000115	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.18e-05	0.000114	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.17e-05	0.000113	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—PPARG—polycystic ovary syndrome	1.17e-05	0.000112	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	1.15e-05	0.00011	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NCOR1—polycystic ovary syndrome	1.15e-05	0.00011	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	1.13e-05	0.000109	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NRG1—polycystic ovary syndrome	1.13e-05	0.000108	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.12e-05	0.000108	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	1.1e-05	0.000106	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	1.09e-05	0.000105	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—SERPINE1—polycystic ovary syndrome	1.05e-05	0.000101	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PPARG—polycystic ovary syndrome	1.03e-05	9.91e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	1.03e-05	9.89e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—POMC—polycystic ovary syndrome	1.02e-05	9.78e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MTHFR—polycystic ovary syndrome	1.01e-05	9.75e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	1.01e-05	9.74e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—INS—polycystic ovary syndrome	1.01e-05	9.72e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	1.01e-05	9.7e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	9.98e-06	9.61e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IRS2—polycystic ovary syndrome	9.64e-06	9.28e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	9.6e-06	9.24e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	9.52e-06	9.17e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	9.1e-06	8.76e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—TH—polycystic ovary syndrome	8.75e-06	8.42e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	8.69e-06	8.36e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	8.51e-06	8.19e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	8.49e-06	8.17e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	8.48e-06	8.17e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IRS1—polycystic ovary syndrome	8.41e-06	8.1e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	8.22e-06	7.91e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.14e-06	7.83e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—INS—polycystic ovary syndrome	8.06e-06	7.76e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	8e-06	7.7e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKT2—polycystic ovary syndrome	7.79e-06	7.5e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	7.57e-06	7.28e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	7.4e-06	7.12e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	7.33e-06	7.05e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	7.14e-06	6.88e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	7.06e-06	6.8e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	6.88e-06	6.62e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	6.81e-06	6.55e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	6.79e-06	6.53e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—POMC—polycystic ovary syndrome	6.79e-06	6.53e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—INS—polycystic ovary syndrome	6.75e-06	6.5e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	6.7e-06	6.45e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	6.45e-06	6.21e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	6.33e-06	6.09e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	6.23e-06	6e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	6.01e-06	5.79e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL6—polycystic ovary syndrome	5.63e-06	5.42e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—TH—polycystic ovary syndrome	5.39e-06	5.19e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	5.24e-06	5.05e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	4.93e-06	4.75e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	4.88e-06	4.69e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—POMC—polycystic ovary syndrome	4.81e-06	4.63e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—INS—polycystic ovary syndrome	4.78e-06	4.6e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.4e-06	4.24e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	4.19e-06	4.04e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.97e-06	3.83e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.71e-06	3.57e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—IL6—polycystic ovary syndrome	3.52e-06	3.39e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3e-06	2.89e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.96e-06	2.85e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.95e-06	2.84e-05	CbGpPWpGaD
